Case 2 Anxiety
Description of anxiety
Definition
Anxiety is an unpleasant and often distressing sense of uneasiness, apprehension and/or nervousness. Anxiety is considered to be a standalone, non-pathological symptom (i.e. a normal response to an environmental stessor such as workplace or examination stress), as well as a central feature of ‘anxiety disorder’, a term that is inclusive of generalised anxiety disorder (GAD), phobias, panic disorder, obsessive–compulsive disorder (OCD) and post-traumatic stress disorder (PTSD).1
Epidemiology
The lifetime prevalence rate of GAD ranges from 10.6 per cent to 16.6 per cent. This disorder is most prevalent in women, and appears to increase with advancing age. For the more specific anxiety disorders, the lifetime prevalence rates range from 0.5–1.3 per cent for OCD, 1.0–1.2 per cent for panic disorder, 1.2–2.1 per cent for PTSD, 3.6–5.3 per cent for phobias and 2.6–6.2 per cent for GAD.2
Aetiology and pathophysiology
Anxiety disorders are complex conditions that appear to originate from a number of causes. Genetic predisposition and/or familial history, for instance, have been associated with panic disorder, GAD, phobias and OCD.3 Physiological factors, including group A beta-hemolytic Streptococcus infection and trauma or postpartum events are, respectively, also implicated in OCD and panic disorder. But most attention has focused on the neurochemical aetiology of these disorders. Elevated central nervous system catecholamine levels (e.g. panic disorder), impaired gamma-amino butyric acid metabolism (e.g. panic disorder), carbon dioxide sensitivity (e.g. panic disorder), abnormal serotoninergic and noradrenergic activity (e.g. GAD and PTSD), reduced dopamine (D2) receptor and transporter binding (e.g. phobias), abnormal number and/or function of serotinergic receptors (e.g. OCD), neurological disease (e.g. OCD), increased limbic system activity (e.g. PTSD), impaired lactate metabolism (e.g. panic disorder), and basal ganglia dysfunction and prefrontal hyperactivity (e.g. OCD) are just some of the many neurochemical causes of these disorders.4
The pathogenesis of anxiety disorders is only partly explained by these physiological elements. The development of these conditions is also influenced by socioenvironmental factors such as stress, illicit drug use (e.g. marijuana and lysergic acid diethylamide, or LSD), diet (e.g. caffeine), poor social support (e.g. PTSD) and the demise of close relationships (e.g. panic disorder). Behavioural elements also may be implicated in the pathogenesis of anxiety disorder, including the development of abnormal or irrational conditioned responses to fearful situations (e.g. panic disorder), life events (e.g. GAD) or stressful situations (e.g. OCD).4,5
Clinical manifestations
Anxiety is an elusive symptom that can manifest in any person, at any time, in any given situation and to any degree. Anxiety can manifest in any health condition and the physiological features of anxiety can mimic other disorders. As a result, distinguishing anxiety from other medical conditions may be a challenge for some clinicians. A critical first step to identifying anxiety disorder is to understand that anxiety is only one symptom of this condition. Other symptoms that commonly manifest in this group of disorders are irritability, poor concentration, insomnia, restlessness, muscle tension, avoidance behaviour, preoccupation with an event or situation, easy fatigability, tachycardia, palpitations, shortness of breath and an exaggerated startle response.1,3,4
The duration of anxiety is also important. Panic disorder, for instance, is an acute condition that manifests rapidly and peaks within 10 minutes. PTSD can be acute (i.e. occurring soon after an event) and chronic (i.e. occurring more than 3 months after an event). Conditions such as GAD, OCD and phobias are chronic and can exist for many months, years or decades. While the intensity of symptoms is often most severe in acute panic disorder, the severity of symptoms in other anxiety disorders varies greatly.1,3,4
Clinical case
33-year-old woman with generalised anxiety disorder
Rapport
Adopt the practitioner strategies and behaviours highlighted in Table 2.1 (chapter 2) to improve client trust, communication and rapport, and to assure the accuracy and comprehensiveness of the clinical assessment.
Medical history
Family history
Mother has depression, father has type 2 diabetes mellitus, paternal grandmother has agoraphobia.
Lifestyle history
Illicit drug use
Diet and fluid intake | |
---|---|
Breakfast | Cornflakes® cereal with skim milk, coffee. |
Morning tea | Coffee. |
Lunch | Wholemeal sandwich with tomato, low fat cheese, lettuce and/or ham. |
Afternoon tea | Coffee, sweet biscuits. |
Dinner | Lamb and vegetable curry, fish in coconut cream, baked cod with tomato and onion, beef meatballs with sweet potato bake. |
Fluid intake | 4–5 cups of percolated coffee a day, 1–2 cups of water a day. |
Food frequency | |
Fruit | 1 serve daily |
Vegetables | 2–3 serves daily |
Dairy | 2 serves daily |
Cereals | 5 serves daily |
Red meat | 1 serve a week |
Chicken | 1 serve a week |
Fish | 3 serves a week |
Takeaway/fast food | 1 time a week |
Physical examination
Inspection
The client is cooperative, well groomed, appropriately dressed and maintains good attention and eye contact. Gait and posture are normal. Skin is dark brown in colour with no abnormal pigmentary signs. Nails are strong and intact. There is no evidence of goitre, proptosis, tremors or virilisation.
Diagnosis
Anxiety (actual), related to emotional stress (anxiety symptoms heighten when husband is away and when work responsibilities increase; anxiety is alleviated when client is not at work), life-changing event (anxiety symptoms emerged around the time the client moved to Australia), poor social support (client’s family is overseas, and husband is frequently away for work – limited access to these social supports may predispose the client to anxiety), and/or excess caffeine intake (high caffeine intake may cause anxiety symptoms in susceptible individuals – the client consumes 4–5 cups of percolated coffee a day, which is equivalent to approximately 360–450 mg of caffeine daily).
Planning
Expected outcomes
Based on the degree of improvement reported in clinical studies that have used CAM interventions for the management of anxiety,6–8 the following are anticipated.
Application
Diet
Low-fat, Mediterranean and/or low-sodium diets (Level II, Strength C, Direction o)
Several studies have examined the effect of diet on psychological function, but there is no convincing evidence that diet, including low-fat, Mediterranean and low-sodium diets, are any more effective than controls or standard diet at improving anxiety or psychological wellbeing.9–11 Thus, rather than prescribe a particular type of diet for this client, it may be more pertinent to increase dietary consumption of foods and nutrients that demonstrate anxiolytic activity (see ‘Nutritional supplementation’ below for specific examples).
Lifestyle
Physical exercise (Level I, Strength A, Direction +)
Increasing levels of physical activity are associated with improvements in physiological and psychological health and wellbeing.12 According to findings from a meta-analysis of 49 RCTs, exercise therapy also demonstrates moderate reductions in anxiety when compared to no-exercise controls or other anxiolytic treatment.13 The anxiolytic effect of exercise appears to be less significant in children and adolescents.14
Relaxation therapy (Level I, Strength A, Direction +)
Relaxation therapy describes a range of mind–body techniques that induce the relaxation response and attenuate sympathetic nervous system activity. Many studies have explored the effectiveness of relaxation therapy in anxiety, including 19 RCTs. A meta-analysis of these RCTs found relaxation therapy to be effective at reducing anxiety, particularly state and trait anxiety, with meditation found to be superior to progressive relaxation, autogenic training and multimethod approaches.6 These findings were consistent across studies, although the significant heterogeneity of these trials, including the various types of anxiety and the range of treatment approaches used, suggests results should be interpreted with caution.
Tai chi (Level II, Strength C, Direction +)
Tai chi is an ancient Chinese therapy often used as a meditative technique, soft martial art or form of physical exercise. It is not surprising, then, that the physical and psychological benefits of tai chi are similar to exercise.15,16 In terms of psychological effects, evidence from a number of RCTs suggests that tai chi is superior to sedentary controls in reducing anxiety,15–17 but given that studies are small and methodologically different, further research is needed before any firm conclusions can be made.
Yoga (Level I, Strength C, Direction +)
Yoga is an ancient Indian practice that integrates stretching, exercise, posture and breathing with meditation. Given that these techniques are likely to induce a relaxation response, yoga may be helpful in alleviating emotional stress and anxiety. Findings from a systematic review of eight controlled clinical trials (including six RCTs)18 and results from four recent trials19–22